1. Home
  2. YDES

as 10-07-2025 3:29pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Nasdaq

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Founded: 2013 Country:
Taiwan
Taiwan
Employees: N/A City: N/A
Market Cap: 1.1B IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 103.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.29 EPS Growth: N/A
52 Week Low/High: $5.30 - $25.00 Next Earning Date: 09-30-2025
Revenue: $510,360 Revenue Growth: 45.76%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: